UPS is upgrading 27 temperature-controlled freight hubs across three continents as demand for biologics and GLP-1 drugs drives a pharmaceutical cold chain boom.

UPS is upgrading 27 temperature-controlled freight hubs across three continents as demand for biologics and GLP-1 drugs drives a pharmaceutical cold chain boom.

UPS is announcing a new investment in healthcare logistics as demand for the temperature-controlled category booms, CNBC has learned exclusively.